Lumen Bioscience awarded $16.2 million to advance C. difficile treatment

Lumen Bioscience has been granted $16.2 million by the U.S. Department of Defense to advance its C. difficile infection (CDI) treatment.

Related Keywords

Carl Mason , ,Lumen Bio ,Bio Developments ,Pipelines ,Markets Amp Regulations ,C Difficile ,Food And Drug Administration ,Lumen Bioscience ,Fda ,